go-v.orgdoi

Immunogenicity and Safety Study of GSK Biologicals' Cell Culture Derived Pandemic Influenza Vaccines GSK2590066A and GSK2592984A Administered to Healthy Adults 18 - 49 Years Old

GlaxoSmithKline · Vivli · 2018

  • DOI 10.25934/00000990
  • Publisher Vivli
  • Type dataset
  • Issued 2018

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Vivli · Vivli · dataset · 2018

Abstract

This study will assess safety and immunogenicity of GSK Biologicals' H5N1 flu candidate vaccines GSK2590066A and GSK2340273A in healthy adults 18 - 49 years old.

Open the resolved locator · 10.25934/00000990

Metadata licence: OpenAlex metadata (CC0)